西点药业
(301130)
| 流通市值：18.63亿 | | | 总市值：24.14亿 |
| 流通股本：5901.74万 | | | 总股本：7649.47万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 55,925,260.77 | 234,840,419.16 | 188,945,385.6 | 128,311,809.27 |
| 营业收入 | 55,925,260.77 | 234,840,419.16 | 188,945,385.6 | 128,311,809.27 |
| 二、营业总成本 | 48,180,633.12 | 222,490,004.98 | 159,135,919.32 | 104,512,163.74 |
| 营业成本 | 15,141,067.29 | 55,742,404.81 | 41,512,253.73 | 28,095,999.14 |
| 税金及附加 | 1,712,417.82 | 7,239,263.27 | 5,476,290.7 | 3,556,736.84 |
| 销售费用 | 19,148,834.58 | 112,226,061.66 | 74,798,184.74 | 48,168,309.18 |
| 管理费用 | 9,731,367.52 | 36,010,672.44 | 29,393,766.93 | 19,071,542.3 |
| 研发费用 | 2,363,952.48 | 11,253,072.96 | 7,978,718.67 | 5,673,710.96 |
| 财务费用 | 82,993.43 | 18,529.84 | -23,295.45 | -54,134.68 |
| 其中:利息费用 | 127,202.36 | 444,830.96 | 362,725.03 | 268,252.26 |
| 其中:利息收入 | 47,824.87 | 450,018.99 | 407,071.91 | 340,599.76 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -79,845.07 | 938,341.28 | 551,037.55 | 526,078.01 |
| 加:投资收益 | 259,711.04 | 2,996,300.69 | 2,552,898.35 | 1,115,374.4 |
| 资产减值损失(新) | -17,087.33 | -994,022.64 | -71,366.75 | -56,416.51 |
| 信用减值损失(新) | -238,633.48 | 160,340.94 | -407,365.7 | -438,432.68 |
| 其他收益 | 2,122,008.01 | 4,769,387.96 | 3,667,779.69 | 1,977,212.89 |
| 四、营业利润 | 9,790,780.82 | 20,220,762.41 | 36,102,449.42 | 26,923,461.64 |
| 加:营业外收入 | 286,394.99 | 782,035.46 | 68,000.81 | 76.81 |
| 减:营业外支出 | 113,747.09 | 6,629.43 | 6,006.83 | 5,825.4 |
| 五、利润总额 | 9,963,428.72 | 20,996,168.44 | 36,164,443.4 | 26,917,713.05 |
| 减:所得税费用 | 1,360,700.29 | 1,098,115.87 | 4,812,174.71 | 3,440,726.65 |
| 六、净利润 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 | 23,476,986.4 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 9,184,829.82 | 21,900,019.04 | 33,146,362.42 | 24,944,585.08 |
| 少数股东损益 | -582,101.39 | -2,001,966.47 | -1,794,093.73 | -1,467,598.68 |
| 扣除非经常损益后的净利润 | 8,043,957.02 | 17,537,029.35 | 29,808,580.48 | 23,386,006.42 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 0.29 | 0.43 | 0.33 |
| (二)稀释每股收益 | 0.12 | 0.29 | 0.43 | 0.33 |
| 九、综合收益总额 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 | 23,476,986.4 |
| 归属于母公司股东的综合收益总额 | 9,184,829.82 | 21,900,019.04 | 33,146,362.42 | 24,944,585.08 |
| 归属于少数股东的综合收益总额 | -582,101.39 | -2,001,966.47 | -1,794,093.73 | -1,467,598.68 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-28 | 2025-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |